Biblio
Export 160 results:
[ Author
Filters: First Letter Of Last Name is G [Clear All Filters]
“Alzheimer's Disease Risk Genes and Lipid Regulators.”, J Alzheimers Dis, vol. 53, no. 1, pp. 15-29, 2016.
, “Palmomental Reflex a Relevant Sign in Early Alzheimer's Disease Diagnosis?”, J Alzheimers Dis, vol. 49, no. 4, pp. 1135-41, 2016.
, “Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1097-1105, 2018.
, “Mitochondria Profoundly Influence Apolipoprotein E Biology.”, J Alzheimers Dis, vol. 92, no. 2, pp. 591-604, 2023.
, “A Blood Test for Alzheimer's Disease: It's about Time or Not Ready for Prime Time?”, J Alzheimers Dis, vol. 90, no. 3, pp. 963-966, 2022.
, “REM Sleep Behavior Disorder and Alzheimer's Disease: Definitely No Relationship?”, J Alzheimers Dis, vol. 63, no. 1, pp. 1-11, 2018.
, “Plasma Screening for Progranulin Mutations in Patients with Progressive Supranuclear Palsy and Corticobasal Syndromes.”, J Alzheimers Dis, vol. 53, no. 2, pp. 445-9, 2016.
, “Associations between the Frailty Index and Brain Atrophy: The Treviso Dementia (TREDEM) Registry.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1623-1634, 2018.
, “Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry.”, J Alzheimers Dis, vol. 50, no. 4, pp. 969-79, 2016.
, “Medical and Social Determinants of Brain Health and Dementia in a Multicultural Community Cohort of Older Adults.”, J Alzheimers Dis, vol. 84, no. 4, pp. 1563-1576, 2021.
, “Rosetta Stone for Amyloid Fibrils: The Key Role of Ring-Like Oligomers in Amyloidogenesis.”, J Alzheimers Dis, vol. 59, no. 3, pp. 785-795, 2017.
, “A Comparison of Well-Being of Carers of People with Dementia and Their Ability to Manage Before and During the COVID-19 Pandemic: Findings from the IDEAL Study.”, J Alzheimers Dis, vol. 88, no. 2, pp. 679-692, 2022.
, “Long-Term Severe Mental Disorders Preceding Behavioral Variant Frontotemporal Dementia: Frequency and Clinical Correlates in an Outpatient Sample.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1577-1585, 2018.
, “INDEL Length and Haplotypes in the β-Synuclein Gene: A Key to Differentiate Dementia with Lewy Bodies?”, J Alzheimers Dis, vol. 65, no. 1, pp. 207-219, 2018.
, “Kidins220 Correlates with Tau in Alzheimer's Disease Brain and Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1327-1333, 2017.
, “Aging-Related Calcium Dysregulation in Rat Entorhinal Neurons Homologous with the Human Entorhinal Neurons in which Alzheimer's Disease Neurofibrillary Tangles First Appear.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1371-1378, 2018.
, “The Level of Plasma Amyloid-β40 Is Correlated with Peripheral Transport Proteins in Cognitively Normal Adults: A Population-Based Cross-Sectional Study.”, J Alzheimers Dis, vol. 65, no. 3, pp. 951-961, 2018.
, “lncRNA SNHG1 Knockdown Alleviates Amyloid-β-Induced Neuronal Injury by Regulating ZNF217 via Sponging miR-361-3p in Alzheimer's Disease.”, J Alzheimers Dis, vol. 77, no. 1, pp. 85-98, 2020.
, “Shared Genetic Etiology between Type 2 Diabetes and Alzheimer's Disease Identified by Bioinformatics Analysis.”, J Alzheimers Dis, vol. 50, no. 1, pp. 13-7, 2016.
, “An 18-mer Peptide Derived from Prosaposin Ameliorates the Effects of Aβ1-42 Neurotoxicity on Hippocampal Neurogenesis and Memory Deficit in Mice.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1173-92, 2016.
, “Microglia CREB-Phosphorylation Mediates Amyloid-β-Induced Neuronal Toxicity.”, J Alzheimers Dis, vol. 66, no. 1, pp. 333-345, 2018.
, “Upregulated Expression of Heparanase and Heparanase 2 in the Brains of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 185-192, 2017.
, “Age of Migration and Cognitive Function Among Older Latinos in the United States.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1493-1511, 2020.
, “Quantitative 3D Telomeric Imaging of Buccal Cells Reveals Alzheimer's Disease-Specific Signatures.”, J Alzheimers Dis, vol. 58, no. 1, pp. 139-145, 2017.
, “Efficacy of Souvenaid® Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1459-1469, 2023.
,